Efluelda Tetra

Efluelda Tetra is a quadrivalent influenza vaccine designed to protect against four strains of the flu virus. It is suitable for intramuscular or subcutaneous use and is manufactured by Sanofi Winthrop Industrie. This vaccine is intended for seasonal flu prevention.

Efluelda Tetra is used to prevent influenza caused by the four strains of the virus included in the vaccine. It is typically administered annually to help reduce the risk of flu infection. The vaccine is suitable for individuals who are at risk of complications from the flu, such as the elderly, young children, and those with chronic health conditions.

Common effects of Efluelda Tetra may include mild soreness, redness, or swelling at the injection site. Some individuals may experience mild flu-like symptoms such as fever, fatigue, or muscle aches. These effects are usually temporary and resolve within a few days.

Efluelda Tetra should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to previous flu vaccines or any of the components in Efluelda Tetra should avoid this vaccine. It is important to inform your healthcare provider about any medical conditions or allergies before receiving the vaccine.

Efluelda Tetra may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving Efluelda Tetra. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.